HomeCompareNVIVQ vs EPRT

NVIVQ vs EPRT: Dividend Comparison 2026

NVIVQ yields 540.54% · EPRT yields 3.97%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 NVIVQ wins by $112786.16M in total portfolio value
10 years
NVIVQ
NVIVQ
● Live price
540.54%
Share price
$0.37
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$112786.22M
Annual income
$82,692,515,806.61
Full NVIVQ calculator →
EPRT
EPRT
● Live price
3.97%
Share price
$30.36
Annual div
$1.21
5Y div CAGR
29%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$64.3K
Annual income
$13,170.85
Full EPRT calculator →

Portfolio growth — NVIVQ vs EPRT

📍 NVIVQ pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodNVIVQEPRT
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, NVIVQ + EPRT cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
NVIVQ pays
EPRT pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

NVIVQ
Annual income on $10K today (after 15% tax)
$45,945.95/yr
After 10yr DRIP, annual income (after tax)
$70,288,638,435.62/yr
EPRT
Annual income on $10K today (after 15% tax)
$337.37/yr
After 10yr DRIP, annual income (after tax)
$11,195.22/yr
At 15% tax rate, NVIVQ beats the other by $70,288,627,240.40/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of NVIVQ + EPRT for your $10,000?

NVIVQ: 50%EPRT: 50%
100% EPRT50/50100% NVIVQ
Portfolio after 10yr
$56393.14M
Annual income
$41,346,264,488.74/yr
Blended yield
73.32%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on EPRT right now

NVIVQ
No analyst data
EPRT
Analyst Ratings
1
Strong
17
Buy
3
Hold
1
Sell
Consensus: Buy
Price Target
$35.50
+16.9% upside vs current
Range: $33.00 — $37.00
Altman Z
1.8
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

NVIVQ buys
0
EPRT buys
0
No recent congressional trades found for NVIVQ or EPRT in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricNVIVQEPRT
Forward yield540.54%3.97%
Annual dividend / share$2.00$1.21
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%29%
Portfolio after 10y$112786.22M$64.3K
Annual income after 10y$82,692,515,806.61$13,170.85
Total dividends collected$110217.05M$38.7K
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: NVIVQ vs EPRT ($10,000, DRIP)

YearNVIVQ PortfolioNVIVQ Income/yrEPRT PortfolioEPRT Income/yrGap
1← crossover$64,754$54,054.05$11,212$512.01+$53.5KNVIVQ
2$396,410$327,123.28$12,689$692.09+$383.7KNVIVQ
3$2,295,726$1,871,567.31$14,521$944.30+$2.28MNVIVQ
4$12,586,137$10,129,710.14$16,841$1,302.88+$12.57MNVIVQ
5$65,369,349$51,902,182.37$19,841$1,821.64+$65.35MNVIVQ
6$321,877,325$251,932,121.38$23,818$2,587.47+$321.85MNVIVQ
7$1,503,762,535$1,159,353,797.14$29,230$3,744.65+$1503.73MNVIVQ
8$6,671,013,644$5,061,987,731.83$36,816$5,540.38+$6670.98MNVIVQ
9$28,124,961,234$20,986,976,635.20$47,806$8,413.17+$28124.91MNVIVQ
10$112,786,224,327$82,692,515,806.61$64,324$13,170.85+$112786.16MNVIVQ

NVIVQ vs EPRT: Complete Analysis 2026

NVIVQStock

InVivo Therapeutics Holdings Corp. operates as a research and clinical-stage biomaterials and biotechnology company in the United States. The company engages in developing and commercializing biopolymer scaffolding devices for the treatment of spinal cord injuries (SCI). It is developing a Neuro-Spinal Scaffold implant comprise of biocompatible and bioresorbable polymers, which includes Poly lactic-co-glycolic acid, a polymer which is widely used in resorbable sutures and provides the biocompatible support for Neuro-Spinal Scaffold implant; and Poly-L-Lysine, a positively charged polymer used to coat surfaces to promote cellular attachment. The company was incorporated in 2003 and is headquartered in Cambridge, Massachusetts.

Full NVIVQ Calculator →

EPRTREIT

Essential Properties Realty Trust, Inc., a real estate company, acquires, owns, and manages single-tenant properties in the United States. The company leases its properties to middle-market companies, such as restaurants, car washes, automotive services, medical and dental services, convenience stores, equipment rental, entertainment, early childhood education, grocery, and health and fitness on a long-term basis. As of December 31, 2021, it had a portfolio of 1, 451 properties. The company qualifies as a real estate investment trust for federal income tax purposes. It generally would not be subject to federal corporate income taxes if it distributes at least 90% of its taxable income to its stockholders. The company was founded in 2016 and is headquartered in Princeton, New Jersey.

Full EPRT Calculator →
📬

Get this NVIVQ vs EPRT comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

NVIVQ vs SCHDNVIVQ vs JEPINVIVQ vs ONVIVQ vs KONVIVQ vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.